TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET 15
1.4 LIMITATIONS 17
1.5 MARKETS COVERED 17
2 MARKET SEGMENTATION 20
2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 22
2.4 CURRENCY AND PRICING 22
2.5 DBMR TRIPOD DATA VALIDATION MODEL 23
2.6 MULTIVARIATE MODELLING 26
2.7 PRODUCT TYPE LIFELINE CURVE 26
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 27
2.9 DBMR MARKET POSITION GRID 28
2.10 MARKET APPLICATION COVERAGE GRID 29
2.11 SECONDARY SOURCES 30
2.12 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 34
4.1 PORTERS FIVE FORCES 35
4.2 PESTEL ANALYSIS 36
4.3 CUSTOMISED DATA: 37
4.3.1 INTRODUCTION 37
5 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET, REGULATIONS 44
6 MARKET OVERVIEW 48
6.1 DRIVERS 50
6.1.1 AGING POPULATION MIDDLE EAST & AFRICALY 50
6.1.2 TECHNOLOGICAL ADVANCEMENTS 50
6.1.3 KEY PLAYERS ARE TAKING STRATEGIC DECISIONS TO GAIN MARKET SHARE 51
6.2 RESTRAINTS 51
6.2.1 STRINGENT REGULATORY POLICIES 51
6.2.2 HIGH COST FOR THE TREATMENTS. 52
6.3 OPPORTUNITIES 52
6.3.1 IMMENT HEALTH REVOLUTION 52
6.3.2 GROWING MEDICAL TOURISM IN ASIA 53
6.4 CHALLENGE 54
6.4.1 INCREASING COMPETITORS 54
7 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE 55
7.1 OVERVIEW 56
7.2 AESTHETIC LASER DEVICES 59
7.2.1 ABLATIVE SKIN RESURFACING DEVICES 60
7.2.1.1 CO2 LASER 60
7.2.1.2 ERBIUM LASER 60
7.2.1.3 OTHERS 60
7.2.2 NON-ABLATIVE FRACTIONAL LASER RESURFACING DEVICES 60
7.2.2.1 RADIOFREQUENCY 61
7.2.2.2 INTENSE PULSED LIGHT 61
7.2.2.3 FRACTIONAL LASER 61
7.2.2.4 THE Q-SWITCHED ND:YAG LASER 61
7.2.2.5 OTHERS 61
7.3 ENERGY DEVICES 61
7.3.1 LASER SURGERY DEVICES 62
7.3.2 ELECTROCAUTERY DEVICES 62
7.3.3 ELECTROSURGERY DEVICES 62
7.3.4 CRYOSURGERY DEVICES 63
7.3.5 HARMONIC SCALPEL 63
7.3.6 MICROWAVE DEVICES 63
7.4 BODY CONTOURING DEVICES 63
7.4.1 LIPOSUCTION 64
7.4.2 NONSURGICAL SKIN TIGHTENING 64
7.4.3 CELLULITE TREATMENT 64
7.5 FACIAL AESTHETIC DEVICES 64
7.5.1 BOTOX INJECTION 65
7.5.2 DERMAL FILLERS 65
7.5.2.1 NATURAL DERMAL FILLERS 66
7.5.2.2 SYNTHETIC DERMAL FILLERS 66
7.5.3 COLLAGEN INJECTIONS 66
7.5.4 CHEMICAL PEEL 66
7.5.5 FACIAL TONING 66
7.5.6 FRAXEL 66
7.5.7 COSMETIC ACUPUNCTURE 66
7.5.8 ELECTROTHERAPY 66
7.5.9 MICRODERMABRASION 66
7.5.10 PERMANENT MAKEUP 67
7.6 AESTHETIC IMPLANTS 67
7.6.1 BREAST AUGMENTATION 68
7.6.1.1 SALINE IMPLANTS 68
7.6.1.2 SILICON IMPLANTS 68
7.6.2 BUTTOCK AUGMENTATION 68
7.6.3 AESTHETIC DENTAL IMPLANTS 69
7.6.3.1 DENTAL TITANIUM IMPLANTS 69
7.6.3.2 DENTAL ZERCONIUM IMPLANTS 69
7.6.4 FACIAL IMPLANTS 69
7.6.5 SOFT TISSUE IMPLANTS 69
7.6.6 TRANSDERMAL IMPLANT 69
7.6.7 OTHERS 69
7.7 SKIN AESTHETIC DEVICES 70
7.7.1 LASER SKIN RESURFACING DEVICES 71
7.7.2 NON SURGICAL SKIN TIGHTENING DEVICES 71
7.7.3 LIGHT THERAPY DEVICES 71
7.7.4 TATTOO REMOVAL DEVICES 71
7.7.5 MICRO-NEEDLING PRODUCTS 72
7.7.6 THREAD LIFT PRODUCTS 72
7.7.7 NAIL TREATMENT LASER DEVICES 72
7.7.8 OTHERS 72
8 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET, BY APPLICATION 73
8.1 OVERVIEW 74
8.2 ANTI-AGING AND WRINKLES 78
8.3 FACIAL AND SKIN REJUVENATION 78
8.4 BREAST ENHANCEMENT 79
8.5 BODY SHAPING AND CELLULITE 80
8.6 TATTOO REMOVAL 80
8.7 VASCULAR LESIONS 81
8.7.1 SEARS, PIGMENT LESIONS, RECONSTRUCTIVE 81
8.8 PSORIASIS AND VITILIGO 82
8.9 OTHERS 83
9 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET, BY END USER 84
9.1 OVERVIEW 85
9.2 COSMETIC CENTERS 88
9.3 DERMATOLOGY CLINICS 88
9.4 HOSPITALS 89
9.5 MEDICAL SPAS AND BEAUTY CENTERS 89
10 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL 90
10.1 OVERVIEW 91
10.2 DIRECT TENDER 93
10.3 RETAIL 94
11 MIDDLE EAST & AFRICA MEDICAL AESTHETIC DEVICES MARKET, BY REGION 95
11.1 MIDDLE EAST AND AFRICA 96
11.1.1 SOUTH AFRICA 100
11.1.2 U.A.E. 100
11.1.3 SAUDI ARABIA 100
11.1.4 REST OF MIDDLE EAST AND AFRICA 100
12 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET: COMPANY LANDSCAPE 101
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 101
13 COMPANY PROFILE 102
13.1 ALLERGAN 102
13.1.1 COMPANY SNAPSHOT 102
13.1.2 SWOT ANALYSIS 103
13.1.3 REVENUE ANALYSIS 104
13.1.4 COMPANY SHARE ANALYSIS 104
13.1.5 PRODUCT PORTFOLIO 105
13.1.6 RECENT DEVELOPMENTS 105
13.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS 106
13.2 BAUSCH HEALTH COMPANIES INC. 107
13.2.1 COMPANY SNAPSHOT 107
13.2.2 SWOT ANALYSIS 108
13.2.3 REVENUE ANALYSIS 109
13.2.4 PRODUCT PORTFOLIO 109
13.2.5 RECENT DEVELOPMENTS 110
13.2.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 110
13.3 LUMENIS 111
13.3.1 COMPANY SNAPSHOT 111
13.3.2 SWOT ANALYSIS 112
13.3.3 COMPANY SHARE ANALYSIS 113
13.3.4 PRODUCT PORTFOLIO 113
13.3.5 RECENT DEVELOPMENTS 114
13.3.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 114
13.4 SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., LTD. 115
13.4.1 COMPANY SNAPSHOT 115
13.4.2 SWOT ANALYSIS 116
13.4.3 REVENUE ANALYSIS 117
13.4.4 PRODUCT PORTFOLIO 117
13.4.5 RECENT DEVELOPMENTS 118
13.4.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 118
13.5 CYNOSURE 119
13.5.1 COMPANY SNAPSHOT 119
13.5.2 SWOT ANALYSIS 120
13.5.3 COMPANY SHARE ANALYSIS 121
13.5.4 PRODUCT PORTFOLIO 121
13.5.5 RECENT DEVELOPMENTS 123
13.5.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 123
13.6 AEROLASE CORP. 124
13.6.1 COMPANY SNAPSHOT 124
13.6.2 PRODUCT PORTFOLIO 124
13.6.3 RECENT DEVELOPMENTS 124
13.7 A.R.C. LASER GMBH 125
13.7.1 COMPANY SNAPSHOT 125
13.7.2 PRODUCT PORTFOLIO 125
13.7.3 RECENT DEVELOPMENT 126
13.8 ASCLEPION LASER TECHNOLOGIES GMBH 127
13.8.1 COMPANY SNAPSHOT 127
13.8.2 PRODUCT PORTFOLIO 127
13.8.3 RECENT DEVELOPMENT 128
13.9 BTL 129
13.9.1 COMPANY SNAPSHOT 129
13.9.2 PRODUCT PORTFOLIO 129
13.9.3 RECENT DEVELOPMENTS 130
13.10 CUTERA 131
13.10.1 COMPANY SNAPSHOT 131
13.10.2 REVENUE ANALYSIS 131
13.10.3 COMPANY SHARE ANALYSIS 132
13.10.4 PRODUCT PORTFOLIO 132
13.10.5 RECENT DEVELOPMENTS 133
13.11 ECLIPSE 134
13.11.1 COMPANY SNAPSHOT 134
13.11.2 PRODUCT PORTFOLIO 134
13.11.3 RECENT DEVELOPMENTS 134
13.12 LUTRONIC 135
13.12.1 COMPANY SNAPSHOT 135
13.12.2 PRODUCT PORTFOLIO 135
13.12.3 RECENT DEVELOPMENTS 136
13.13 MENTOR WORLDWIDE LLC 137
13.13.1 COMPANY SNAPSHOT 137
13.13.2 REVENUE ANALYSIS 137
13.13.3 COMPANY SHARE ANALYSIS 138
13.13.4 PRODUCT PORTFOLIO 138
13.13.5 RECENT DEVELOPMENT 139
13.14 MERZ PHARMA 140
13.14.1 COMPANY SNAPSHOT 140
13.14.2 PRODUCT PORTFOLIO 140
13.14.3 RECENT DEVELOPMENTS 141
13.15 QUANTA SYSTEM 142
13.15.1 COMPANY SNAPSHOT 142
13.15.2 PRODUCT PORTFOLIO 142
13.15.3 RECENT DEVELOPMENTS 143
13.16 SCITON INC. 144
13.16.1 COMPANY SNAPSHOT 144
13.16.2 PRODUCT PORTFOLIO 144
13.16.3 RECENT DEVELOPMENTS 145
13.17 SHARPLIGHT TECHNOLOGIES INC 146
13.17.1 COMPANY SNAPSHOT 146
13.17.2 PRODUCT PORTFOLIO 146
13.17.3 RECENT DEVELOPMENT 147
13.18 SYNERON MEDICAL LTD. 148
13.18.1 COMPANY SNAPSHOT 148
13.18.2 PRODUCT PORTFOLIO 148
13.18.3 RECENT DEVELOPMENTS 150
13.19 VENUS CONCEPT 151
13.19.1 COMPANY SNAPSHOT 151
13.19.2 PRODUCT PORTFOLIO 151
13.19.3 RECENT DEVELOPMENTS 153
14 QUESTIONNAIRE 154
15 RELATED REPORTS 160

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.